COLD SORE FEVER BLISTER TREATMENT- docosanol cream 
Chain Drug Consortium, LLC

----------

Docosanol Cream, 10%

Active ingredient

 Docosanol  10%

Purpose

Cold sore/fever blister treatment

Uses

Warnings

Allergy Alert: This product may cause a severe allergic reaction. Symptoms may include:

If an allergic reaction occurs, stop use and seek medical help right away.

For external use only

Do not use

When using this product

Stop use and ask a doctor if

Keep out of reach of children.

 If swallowed, get medical help or contact a Poison Control Center right away.

Directions

Other information

Inactive ingredients

benzyl alcohol, light mineral oil, propylene glycol, purified water, sucrose distearate, sucrose stearate

Questions or comments?

Call 1-877-753-3935 Monday-Friday 9AM-5PM EST

Principal Display Panel

COMPARE TO THE ACTIVE INGREDIENT IN ABREVA®**

Cold Sore / Fever Blister Treatment

Docosanol Cream, 10%

Non-prescription Medicine to Shorten Healing  Time*

Cold Sore Treatment

For Topical Use Only

NET WT 2 g (0.07 oz)

**This product is not manufactured or distributed by GSK Consumer Healthcare, distributor of Abreva®.

* Non-prescription cold sore medicine to shorten healing time and duration of symptoms.

RETAIN THIS INSERT FOR FULL PRODUCT USES, DIRECTIONS AND WARNINGS

Distributed by:

Pharmacy Value Alliance, LLC

407 East Lancaster Avenue

Wayne, PA 19087

Package Label

Docosanol 10%

PREMIER VALUE Cold Sore Fever Blister Treatment

COLD SORE FEVER BLISTER TREATMENT 
docosanol cream
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:68016-344
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
DOCOSANOL (UNII: 9G1OE216XY) (DOCOSANOL - UNII:9G1OE216XY) DOCOSANOL100 mg  in 1 g
Inactive Ingredients
Ingredient NameStrength
BENZYL ALCOHOL (UNII: LKG8494WBH)  
LIGHT MINERAL OIL (UNII: N6K5787QVP)  
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
WATER (UNII: 059QF0KO0R)  
SUCROSE DISTEARATE (UNII: 33X4X4B90S)  
SUCROSE STEARATE (UNII: 274KW0O50M)  
Product Characteristics
ColorwhiteScore    
ShapeSize
FlavorImprint Code
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:68016-344-071 in 1 PACKAGE06/01/2021
12 g in 1 TUBE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
ANDAANDA20875406/01/2021
Labeler - Chain Drug Consortium, LLC (101668460)

Revised: 9/2021
Document Id: b4fa1ef6-e029-4bf7-9c44-1ed4c6a3415f
Set id: 86406372-9e95-43b9-b275-5661141a085b
Version: 2
Effective Time: 20210922
 
Chain Drug Consortium, LLC